A multicentre study evaluating the risk and prevalence of diabetic retinopathy in children and young people with type 1 diabetes mellitus

Donaghue, 2014, ISPAD Clinical Practice Consensus Guidelines 2014. Microvascular and macrovascular complications in children and adolescents, Pediatr Diabetes, 15, 257, 10.1111/pedi.12180 Feltbower, 2008, Acute complications and drug misuse are important causes of death for children and young adults with type 1 diabetes: results from the Yorkshire Register of diabetes in children and young adults, Diabetes Care, 31, 922, 10.2337/dc07-2029 Klein, 1960, The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years, Archives of ophthalmology (Chicago, Ill, 102, 520, 10.1001/archopht.1984.01040030398010 Sjolie, 1997, Retinopathy and vision loss in insulin-dependent diabetes in Europe. The EURODIAB IDDM Complications Study, Ophthalmology, 104, 252, 10.1016/S0161-6420(97)30327-3 Klein, 2008, The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes, Ophthalmology, 115, 1859, 10.1016/j.ophtha.2008.08.023 Shotliff, 2006, Diabetic retinopathy: summary of grading and management criteria, Practical Diabetes International, 23, 418, 10.1002/pdi.1029 Harding, 2003, Extracts from "concise clinical evidence". Diabetic retinopathy, BMJ (Clinical research ed), 326, 1023, 10.1136/bmj.326.7397.1023 LeCaire, 2006, Lower-than-Expected prevalence and severity of retinopathy in an incident cohort followed during the first 4–14 Years of type 1 diabetes: the Wisconsin diabetes registry study, Am J Epidemiol, 164, 143, 10.1093/aje/kwj166 Bailey, 1999, The national diabetic retinopathy laser treatment Audit. III. Clinical outcomes, Eye, 13, 151, 10.1038/eye.1999.42 Deckert, 1967, Prognosis of proliferative retinopathy in juvenile diabetics, Diabetes, 16, 728, 10.2337/diab.16.10.728 NG18 Diabetes, 2015, (type 1 and type 2) in children and young people: diagnosis and management Hietala, 2010, Age at onset and the risk of proliferative retinopathy in type 1 diabetes, Diabetes Care, 33, 1315, 10.2337/dc09-2278 Downie, 2011, Continued reduction in the prevalence of retinopathy in adolescents with type 1 diabetes: role of insulin therapy and glycemic control, Diabetes Care, 34, 2368, 10.2337/dc11-0102 Tanner, 1975, Prediction of adult height from height, bone age, and occurrence of menarche, at ages 4 to 16 with allowance for midparent height, Arch Dis Child, 50, 14, 10.1136/adc.50.1.14 Mogensen, 1995, Prevention of diabetic renal disease with special reference to microalbuminuria, Lancet, 346, 1080, 10.1016/S0140-6736(95)91747-0 Royal College of Pediatrics and Child Health Yau, 2012, Global prevalence and major risk factors of diabetic retinopathy, Diabetes Care, 35, 556, 10.2337/dc11-1909 Cho, 2011, Microvascular complications assessment in adolescents with 2- to 5-yr duration of type 1 diabetes from 1990 to 2006, Pediatr Diabetes, 12, 682, 10.1111/j.1399-5448.2011.00762.x Fritsch, 2011, Predictors of diabetic ketoacidosis in children and adolescents with type 1 diabetes. Experience from a large multicentre database, Pediatr Diabetes, 12, 307, 10.1111/j.1399-5448.2010.00728.x LeCaire, 2013, Assessing progress in retinopathy outcomes in type 1 diabetes: comparing findings from the Wisconsin diabetes registry study and the Wisconsin epidemiologic study of diabetic retinopathy, Diabetes Care, 36, 631, 10.2337/dc12-0863